Alto Named to 2023 CNBC Disruptor 50 List
At Alto, our mission is to fulfill medicine’s true purpose — to improve quality of life — for everyone who needs it. By putting patients first, we’re increasing accessibility to medicine, improving prescription adherence and making a meaningful difference in the lives of patients.
Today, Alto was named to the 2023 CNBC Disruptor 50. This annual list recognizes private companies that are chasing some of the market’s biggest opportunities, and growing despite a tough capital markets environment and slowing economy. We are grateful to be included among these incredible companies, and humbled by this recognition of our business model, operations, and value proposition.
Despite the challenging economic headwinds that all industries are facing, we’ve remained competitive, agile, and committed to delivering outstanding patient care. Just last year, we launched Essentials from Alto, allowing customers to purchase pharmacy items along with their prescription medication in the Alto pharmacy app. This provides even more access to individuals who are disabled, lack physical mobility, or otherwise can’t reach a pharmacy.
As we celebrate this achievement, we are also mindful of the challenges that lie ahead. The healthcare industry is complex, and there is still much work to be done to ensure that every patient receives the care they deserve. But with our innovative offerings and unwavering commitment to our customers, we are confident that we can make an even bigger difference.